Алгоритмы специализированной медицинской помощи больным сахарным диабетом / Под ред. И.И. Дедова, М.В. Шестаковой. - 2-е изд. - М., 2006.
Дедов И.И., Фадеев В.В. Введение в диабетологию: Руководство для врачей. - М.: Берег, 2000.
Сахарный диабет: Руководство для врачей / Под ред. И.И. Дедова, М.В. Шеста-ковой. - М.: Универсум Паблишинг, 2003.
Chiasson J.L., Josse R.G., Gomis R., et al. For the STOP-NIDDM Trial Research Group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial // Lancet. - 2002. - Vol. 359. - P. 2072-2077.
Davis S.N., Granner D.K. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: J.G. Hard-man, L.E. Limbird, Eds. / Goodman & Gilman's The Pharmacologic Basis of Therapeutics, 10th ed. - New York: McGraw-Hill, 2001. - Р. 1679-1714.
Diabetes Prevention Research Group-Reduction in the evidence of type 2 diabetes with life-style intervention or metformin // New Engl. J. Med. - 2002. - Vol.346. - P. 393-403.
Lacy C.F., Armstrong L.L., Goldman M.P., Lance L.L. Drug Information Handbook. - 11th ed. - Lexi-Comp, 2003.
Nesto R.W., Bell D., Bonow R.O., Fonseca V. et al. Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure. A Consensus Statement From the American Heart Association and American Diabetes Association // Circulation. - 2003. - 108: P. 2941-2948.
Salpeter S.R., Greyber E., Pasternak G.A. et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis // Arch. Intern. Med. - 2003. - Vol. 163. - P. 2594-2602.
UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) // Lancet. - 1998. - Vol. 352. - P. 854-865.